Research programme: oral insulin/insulin sensitiser - DiabetologyAlternative Names: Combulin
Latest Information Update: 30 Sep 2015
At a glance
- Originator Diabetology
- Class Insulins
- Mechanism of Action Ornithine decarboxylase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Type 2 diabetes mellitus
Most Recent Events
- 30 Sep 2015 Preclinical development is ongoing in United Kingdom (Diabetology pipeline, September 2015)
- 30 May 2005 Preclinical trials in Type-2 diabetes mellitus in United Kingdom (PO)